Prof James Rucker, of King\u2019s College London\u2019s institute of psychiatry, psychology and neuroscience (IoPPN) and consultant psychiatrist at SLaM, said: \u201cHere, we show that a randomised trial design of psilocybin compared to a true placebo was feasible in participants who had often failed many different types of treatment.<\/p>\n
\u201cPeople who were randomised to receive a dose of 25mg of psilocybin were much more likely to improve than those who were randomised to placebo up to six weeks of follow up.<\/p>\n
\u201cAs is often the case in clinical depression, individual responses were very variable and some of the difference seen between groups will be due to non-drug factors.<\/p>\n
\u201cPublicly funded clinical trials are an important part of the jigsaw of evidence needed for a new intervention to find its place in the real world.<\/p>\n
\u201cMeanwhile, the wider evidence base for psilocybin therapy is growing rapidly, and looks increasingly promising.\u201d<\/p>\n
Recruitment for the trial started at a research facility before continuing at a community mental health building.<\/p>\n
Catherine Bird, senior clinical trials manager at the IoPPN, said it showed that \u201cpsilocybin, unlike many psychiatric drugs, can be administered safely outside a hospital ward\u201d and required a \u201ccalm, supported environment and trained staff rather than medical monitoring\u201d.<\/p>\n
Prof Rucker added: \u201cThis trial makes a strong case for larger publicly funded trials of psilocybin therapy in community settings, which are often more convenient and less anxiety-provoking for patients than hospital settings.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Prof James Rucker, of King\u2019s College London\u2019s institute of psychiatry, psychology and neuroscience (IoPPN) and consultant psychiatrist at…\n","protected":false},"author":2,"featured_media":563069,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[3419,1757,134,8284,554,555,111,43,139,69,1177,1252],"class_list":["post-563068","post","type-post","status-publish","format-standard","has-post-thumbnail","category-mental-health","tag-depression","tag-drugs","tag-health","tag-health-news","tag-mental-health","tag-mentalhealth","tag-new-zealand","tag-news","tag-newzealand","tag-nz","tag-standard","tag-uk-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/563068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=563068"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/563068\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/563069"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=563068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=563068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=563068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}